Six years since the FDA blessed Sanofi and Regeneron’s Dupixent as the first biologic to treat chronic rhinosinusitis with ...
Shares of Disc Medicine jumped after the company said it received a Commissioner's National Priority Voucher from the Food and Drug Administration for its drug bitopertin. The stock climbed 27% to $94 ...
TipRanks on MSN
Disc Medicine Receives FDA Priority Voucher for Bitopertin
Disc Medicine ( ($IRON) ) has shared an announcement. On October 16, 2025, Disc Medicine announced it received a Commissioner’s National Priority ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback